Company intelligence / Profile preview

SHL Medical

Ownership: Private
Employees: ~5000
Development stage: Commercial

Overview

SHL Medical has launched over 50 combination products globally—40+ in autoinjector formats—enabling self-injection for millions of patients with chronic conditions. Their technologies are widely adopted by leading pharma/biotech companies for commercialized therapies.

Therapeutic areas: Endocrinology
Modalities: Device (autoinjectors, pen injectors, wearable drug delivery systems)
Industry: Therapeutic Medical Devices

Partnerships

Partners with most of the world’s top 25 pharmaceutical companies including global leaders in biologics and biosimilarsStrategic partnerships include Innovation Zed and QuiO for digital health solutions.

Beyond the preview

Go deeper on SHL Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHL Medical.

Explore the full profile